University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Alabama at Birmingham - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013496
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Alabama at Birmingham (UAB), a subsidiary of University of Alabama System is an educational university that offers undergraduate and graduate programs. The university provides graduate programs in arts and sciences, health professions, medicine, nursing, business, dentistry, education, engineering, optometry and public health areas. It also provides student affair programs that include career and professional development, dining, housing and residence life, hill student center, student life, one stop student services, campus recreation, disability support services, and student health and wellness. The university also offers resources for researchers such as research portal, clinical trials, compliance training and post-doctoral training. UAB is headquartered in Birmingham, Alabama, the US.

University of Alabama at Birmingham – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Alabama at Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Alabama at Birmingham, Medical Devices Deals, 2011 to YTD 2017 10
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
CRISPR Enters into Agreement with University of Alabama 13
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 14
Proton International Enters into Agreement with University of Alabama at Birmingham 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 17
Licensing Agreements 18
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 18
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 19
University Of Alabama Enters Into Licensing Agreement With Illumina 20
LipimetiX Amends its Licensing Agreement with UAB Research Foundation 21
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 22
Janus Developments Enters Into Licensing Agreement With University of Alabama at Birmingham 23
University of Alabama at Birmingham – Key Competitors 24
University of Alabama at Birmingham – Key Employees 25
University of Alabama at Birmingham – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Legal and Regulatory 27
Sep 01, 2016: NSF approves UAB Center for Health Organization Transformation 27
Aug 10, 2016: New guidelines published for physicians treating patients with kidney stones 28
Government and Public Interest 29
Nov 16, 2017: UAB physician-scientist receives Komen grant to conduct HER2-positive breast cancer research 29
Nov 16, 2017: First Ever Effective Intervention Against Dementia Shown in Large Study 30
Nov 07, 2017: Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs 32
Oct 26, 2017: Multi-site study will examine cognitive behavior therapy for traumatic brain injury-induced seizures 34
Oct 26, 2017: Study shows brain structures make some people resilient to Alzheimer’s disease 35
Oct 16, 2017: Plant-based diet converts breast cancer in mice from lethal to treatable form 37
Oct 13, 2017: CRISPR Therapeutics Awarded Grant From Friedreich’s Ataxia Research Alliance to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedrich’s Ataxia 39
Oct 09, 2017: Translational researchers at UAB received a $6.5 million grant to further investigate gout and associated diseases 40
Oct 04, 2017: Care could improve for dialysis patients with development of bionanomatrix gel with $2 million grant 41
Oct 02, 2017: Preventing autoimmune disease after a viral infection 43
Aug 09, 2017: Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model 44
Jul 11, 2017: Dry eye relief progresses with new guidelines and expansion of UAB’s Dry Eye Relief Clinic 46
Sep 07, 2016: Stealth pig cells may hold the key to treating diabetes in humans 47
Aug 23, 2016: Discovery of mechanism that alters neural excitability offers window into neuropsychiatric disease 49
Aug 22, 2016: UAB study finds potential treatment target for Guillain-Barré syndrome 50
Aug 17, 2016: Advancements in aging research target multiple age-related diseases 52
Jul 28, 2016: Acute kidney injury identifiable in preterm infants 54
Jul 21, 2016: Precision medicine clinical trial available for cancer patients at UAB 55
Jul 14, 2016: UAB researchers awarded $11.5 million to study asymptomatic congenital CMV and neonatal HSV 56
Jul 13, 2016: UAB researcher receives funding for rheumatology study 57
Jul 06, 2016: HudsonAlpha and UAB awarded NIH training grant 58
Jul 06, 2016: BCRFA announces funding opportunity for collaborative breast cancer research 59
Jul 05, 2016: Parkinson’s disease biomarker found in patient urine samples 60
May 16, 2016: HIV vaccine design should adapt as HIV virus mutates 62
Feb 18, 2016: Surgery and stenting safe, effective lowering long-term risk of stroke 63
Feb 15, 2016: Cell marker found for leukemia-initiating capacity in chronic myelogenous leukemia 64
Feb 12, 2016: REGARDS data show diabetics who use verapamil have lower glucose levels 66
Product News 67
Feb 01, 2017: Researchers develop best-yet cell culture system for age-related macular degeneration 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Key Facts 2
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Alabama at Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Alabama at Birmingham, Deals By Therapy Area, 2011 to YTD 2017 9
University of Alabama at Birmingham, Medical Devices Deals, 2011 to YTD 2017 10
University of Alabama at Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
CRISPR Enters into Agreement with University of Alabama 13
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 14
Proton International Enters into Agreement with University of Alabama at Birmingham 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Synedgen Enters Into Research Agreement With Cincinnati Children’s Hospital Medical Center And University Of Alabama 17
IURTC and University of Alabama at Birmingham Enter into Licensing Agreement with La Jolla Pharma 18
Incysus Enters into Licensing Agreement with Emory University, Children’s Hospital of Atlanta and University of Alabama at Birmingham 19
University Of Alabama Enters Into Licensing Agreement With Illumina 20
LipimetiX Amends its Licensing Agreement with UAB Research Foundation 21
Janus Developments Enters Into Licensing Agreement With UAB And ICMAB 22
Janus Developments Enters Into Licensing Agreement With University of Alabama at Birmingham 23
University of Alabama at Birmingham, Key Competitors 24
University of Alabama at Birmingham, Key Employees 25
University of Alabama at Birmingham, Subsidiaries 26

★海外企業調査レポート[University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ET Solar Group Corporation-エネルギー分野:企業M&A・提携分析
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a wide variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and …
  • M3 Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary M3 Midstream LLC (Momentum) is an independent oil and gas company that offers midstream oilfield services. The company provides services such as gas processing and treating, wellhead gathering, dehydration, fractionation, compression, and storage services for natural gas and natural gas liqu …
  • Ontario Municipal Employees Retirement System:電力:M&Aディール及び事業提携情報
    Summary Ontario Municipal Employees Retirement System (OMERS) offers pension benefits to government employees, beneficiaries, and retirees from diverse sectors such as municipalities, libraries, police and fire departments, schools, and other agencies in Ontario. It is sponsored by OMERS Sponsors Co …
  • Anhui Water Resources Development Co Ltd (600502):企業の財務・戦略的SWOT分析
    Summary Anhui Water Resources Development Co Ltd (Anhui Water) is an investment holding company. The company operates in the business of construction, real estate development, and hydropower investment construction and operation. It operates as a general contractor of water conservancy projects, hou …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • China Resources Zizhu Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Zizhu Pharmaceutical Co Ltd (Zizhu Pharmaceutical) is a provider of pharmaceutical development, manufacture, and marketing programs. The company offers dietary supplements, women healthcare products, ophthalmology medicines, APIs and intermediates, anesthetic, biological agen …
  • Shandong Airlines Co., Ltd.:企業の戦略・SWOT・財務分析
    Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • RegenxBio Inc (RGNX):企業の財務・戦略的SWOT分析
    RegenxBio Inc (RGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Hong Kong and China Gas Co Ltd (3):石油・ガス:M&Aディール及び事業提携情報
    Summary The Hong Kong and China Gas Company Limited (Towngas) is an energy company that produces distributes and markets the gas, water and related activities in Hong Kong and China. The company also carries out the LPG filling stations and utilization of landfill gas. The company has interests in v …
  • LeadFX Inc.:企業のM&A・事業提携・投資動向
    LeadFX Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LeadFX Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • Spark Therapeutics Inc (ONCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • The Wharf (Holdings) Limited
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Southwest Gas Corporation (SWX):企業の財務・戦略的SWOT分析
    Southwest Gas Corporation (SWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • LinkedIn Corp:企業の戦略的SWOT分析
    LinkedIn Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Binx Health Inc:企業の製品パイプライン分析
    Summary Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for women’s health. The company develops its proprietary, desktop, PCR-based point-of-care molecular diagnostic platform for diagnosis and treatment for chl …
  • Exelon Corporation:発電所・企業SWOT分析
    Exelon Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Clean Energy Fuels Corp (CLNE):企業の財務・戦略的SWOT分析
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆